Human Reproduction Update, Vol.4, No.5 pp.565-569, 1998
© European Society of Human Reproduction and Embryology 1998; all rights reserved
Nitric oxide in the endometrium
Department of Obstetrics and Gynaecology, University of Glasgow, The Queen Mother's Hospital, Yorkhill, Glasgow G3 8SJ, UK 0 Corresponding author
Abstract
Nitric oxide (NO) is an important mediator of paracrine interactions, especially within the vascular system. It is a powerful inhibitor of platelet aggregation and a potent vasodilator. NO is also a neurotransmitter and it plays a role in cell-mediated cytotoxicity. NO-generating enzymes (nitric oxide synthases, NOS) have been described in the endometrium of a number of species, suggesting that NO might be involved in endometrial function. In human endometrium, endothelial NOS and inducible NOS have been localized to glandular epithelium in the non-pregnant uterus. Weak inducible NOS immunoreactivity has been observed in decidualized stromal cells. NO might participate in the initiation and control of menstrual bleeding. Furthermore, it may play a part in the inhibition of platelet aggregation within the endometrium, where menstrual haemostasis is thought to occur primarily by vasoconstriction rather than clot organization. Endometrially derived NO could also suppress myometrial contractility. Recent attention has focused on the part that NO might play in maintaining myometrial quiescence during pregnancy. NO also appears to relax the non-pregnant myometrium, an action which could be exploited for the medical treatment of primary dysmenorrhoea.
Keywords:endometrium/human/nitric oxide
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. H. Ruder, T. J. Hartman, J. Blumberg, and M. B. Goldman Oxidative stress and antioxidants: exposure and impact on female fertility Hum. Reprod. Update, June 4, 2008; (2008) dmn011v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Miech Pathopharmacology of Excessive Hemorrhage in Mifepristone Abortions Ann. Pharmacother., December 1, 2007; 41(12): 2002 - 2007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Kazi, J. M. Jones, and R. D. Koos Chromatin Immunoprecipitation Analysis of Gene Expression in the Rat Uterus in Vivo: Estrogen-Induced Recruitment of Both Estrogen Receptor {alpha} and Hypoxia-Inducible Factor 1 to the Vascular Endothelial Growth Factor Promoter Mol. Endocrinol., August 1, 2005; 19(8): 2006 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Print, R. Valtola, A. Evans, K. Lessan, S. Malik, and S. Smith Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome Hum. Reprod., October 1, 2004; 19(10): 2356 - 2366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ohl, C. Lefebvre-Maunoury, C. Wittemer, G. Nisand, M.-C. Laurent, and P. Hoffmann Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial Hum. Reprod., October 1, 2002; 17(10): 2615 - 2620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Cornwell, J. Li, H. Sellak, P. de Lanerolle, W. H. Rodgers, R. T. Miller, and R. Ann Word Regulation of Cyclic Guanosine Monophosphate-Dependent Protein Kinase in Human Uterine Tissues During the Menstrual Cycle Biol Reprod, March 1, 2001; 64(3): 857 - 864. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Skarzynski, Y. Miyamoto, and K. Okuda Production of Prostaglandin F2{alpha} by Cultured Bovine Endometrial Cells in Response to Tumor Necrosis Factor {alpha}: Cell Type Specificity and Intracellular Mechanisms Biol Reprod, May 1, 2000; 62(5): 1116 - 1120. [Abstract] [Full Text]
|
|
|
|
|
|
G. Sher and J. D. Fisch Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF Hum. Reprod., April 1, 2000; 15(4): 806 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Taguchi, J. Alfer, K. Chwalisz, H.M. Beier, and I. Classen-Linke Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle Mol. Hum. Reprod., February 1, 2000; 6(2): 185 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ekerhovd, M. Brannstrom, B. Weijdegard, and A. Norstrom Localization of nitric oxide synthase and effects of nitric oxide donors on the human Fallopian tube Mol. Hum. Reprod., November 1, 1999; 5(11): 1040 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zervou, L.D. Klentzeris, and R.W. Old Nitric oxide synthase expression and steroid regulation in the uterus of women with menorrhagia Mol. Hum. Reprod., November 1, 1999; 5(11): 1048 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Manabe, T. Hata, T. Yanagihara, M. Hashimoto, Y. Yamada, S. Irikoma, S. Aoki, S. Masumura, and K. Miyazaki Nitric oxide synthesis is increased after dehydroepiandrosterone sulphate administration in term human pregnancy Hum. Reprod., August 1, 1999; 14(8): 2116 - 2119. [Abstract] [Full Text] [PDF]
|
|